Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Understanding Physical Activity and Quality of Life in Children and Young People with Chronic Kidney Disease [NA]
Clinical trial update examining physical activity and quality of life in children and young people with chronic kidney disease (stages 3–5);…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database Analysis
A retrospective database analysis assesses how frequently erythropoietin hyporesponsiveness occurs in chronic kidney disease and the associa…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Physical Activity Level in Patients with Chronic Kidney Disease During COVID-19 Pandemic
Completed clinical trial assessing physical activity levels in patients with chronic kidney disease during the COVID-19 pandemic.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization [Phase 4]
Phase 4 clinical trial update evaluating the benefit of the transradial approach for cardiac catheterization in patients with chronic kidney…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: KidneYou - Innovative Digital Therapy [NA]
Completed clinical trial update for KidneYou, an innovative digital therapy from Advice Pharma Group srl, investigating use in chronic kidne…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure [Phase 4]
This Phase 4 clinical trial compares continued immunosuppression versus stopping immunosuppression at six months in patients with late renal…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis [Phase 1]
Phase 1 clinical trial update evaluating pharmacokinetics and safety of ASP7991 in chronic kidney disease patients on hemodialysis.
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Endovascular Preparation for Kidney Tranplantation
Clinical trial update for Endovascular Preparation for Kidney Transplantation. Sponsored by Hospices Civils de Lyon, the study is currently …
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures [NA]
This clinical trial aims to test transcutaneous auricular neurostimulation to reduce blood loss during dialysis arteriovenous graft placemen…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan [Phase 1]
Astellas-sponsored Phase 1 single- and multiple-dose study in Japanese patients with hyperphosphatemia undergoing hemodialysis (in the conte…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction [Phase 1]
A Phase 1 trial of PF-07081532 in people with type 2 diabetes mellitus and chronic kidney disease was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Determining the Effect of Individualized Education Program in Kidney Transplant Patients [NA]
A completed clinical trial evaluating the effect of an individualized education program in kidney transplant patients.
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record [Phase 4]
This is a Phase 4 pragmatic trial comparing empagliflozin and dapagliflozin, embedded in the electronic health record using cluster randomiz…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients
This clinical trial investigates pharmacogenomic factors influencing mood disorders in patients with chronic kidney disease and is currently…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Neutrophil-to-Lymphocyte and Platelet-to-lymphocyte Ratios as a Predictor Factors for Chronic Kidney Disease Progression
A planned study by Assiut University evaluates whether neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios can predict progression of…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Resveratrol and Vascular Function in CKD [NA]
A completed clinical trial evaluated the effect of resveratrol on vascular function in individuals with chronic kidney disease and endotheli…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia [Phase 3]
Astellas reports completion of a Phase 3 study evaluating intermittent oral dosing of ASP1517 in non-dialysis chronic kidney disease patient…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease [Phase 2]
A Phase 2 study evaluating ASP8232 as add-on therapy to ACE inhibitors or ARBs to reduce albuminuria in patients with type 2 diabetes and ch…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia [Phase 3]
Phase 3 trial of intermittent oral dosing of ASP1517 in ESA-untreated chronic kidney disease patients with anemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register
This completed observational trial from Astellas Pharma Europe Ltd. evaluated the epidemiology of anemia in patients with chronic kidney dis…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Retrospective Analysis Assessing Clinical Risk Factors for Cardiovascular Events and Mortality and Development of a Risk Calculator in Chronic Kidney Disease Stage 5 on Dialysis
This clinical trial update reports a retrospective analysis of clinical risk factors for cardiovascular events and mortality in patients wit…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease
A non-interventional, registry-based evaluation conducted in Sweden to investigate anemia in patients with chronic kidney disease; the study…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Effect of a Concurrent Physical Exercise Program in Hemodialysis Patients [NA]
A completed clinical trial evaluated the effect of a concurrent physical exercise program in patients undergoing hemodialysis for chronic ki…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment [Phase 3]
This document reports the completion of a Phase 3 long-term trial of intermittent oral ASP1517 in hemodialysis patients with anemia due to c…
-
CLINICAL_TRIALS other · 2024-10-31Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the pharmacokinetics, pharmacodynamics, and safety of ASP8232 in subjects with chronic kidney disease…